Clinical Characteristics of Post-COVID-19 Persistent Cough in the Omicron Eraopen access
- Authors
- Kang Yu Ri; Huh Jin-Young; Oh Ji-Yoon; Lee Ji-Hyang; Lee Daegeun; Kwon Hyouk-Soo; Kim Tae-Bum; Choi Jae Chol; Cho You Sook; Chung Kian Fan; Park So-Young; Song Woo-Jung
- Issue Date
- May-2023
- Publisher
- 대한천식알레르기학회
- Keywords
- Cough; COVID-19; asthma; Omicron era; cohort; longitudinal assessment; nitric oxide; post-COVID syndrome
- Citation
- Allergy, Asthma & Immunology Research, v.15, no.3, pp 395 - 405
- Pages
- 11
- Journal Title
- Allergy, Asthma & Immunology Research
- Volume
- 15
- Number
- 3
- Start Page
- 395
- End Page
- 405
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/73606
- DOI
- 10.4168/aair.2023.15.3.395
- ISSN
- 2092-7355
2092-7363
- Abstract
- Cough is one of the most common symptoms of acute coronavirus disease 2019, but cough may persist for weeks or months. This study aimed to examine the clinical characteristics of patients with post-coronavirus disease (COVID) persistent cough in the Omicron era. We conducted a pooled analysis comparing 3 different groups: 1) a prospective cohort of post-COVID cough (> 3 weeks; n = 55), 2) a retrospective cohort of post-COVID cough (> 3 weeks; n = 66), and 3) a prospective cohort of non-COVID chronic cough (CC) (> 8 weeks; n = 100). Cough and health status was assessed using patient-reported outcomes (PROs). Outcomes, including PROs and systemic symptoms, were longitudinally evaluated in the prospective post-COVID cough registry participants receiving usual care. A total of 121 patients with post-COVID cough and 100 with non-COVID CC were studied. Baseline cough-specific PRO scores did not significantly differ between post-COVID cough and non-COVID CC groups. There were no significant differences in chest imaging abnormality or lung function between groups. However, the proportions of patients with fractional exhaled nitric oxide (FeNO) ≥ 25 ppb were 44.7% in those with post-COVID cough and 22.7% in those with non-COVID CC, which were significantly different. In longitudinal assessment of the post-COVID registry (n = 43), cough-specific PROs, such as cough severity or Leicester Cough Questionnaire (LCQ) scores, significantly improved between visits 1 and 2 (visit interval: median 35 [interquartile range, IQR: 23–58] days). In the LCQ score, 83.3% of the patients showed improvement (change ≥ +1.3), but 7.1% had worsened (≤ −1.3). The number of systemic symptoms was median 4 (IQR: 2–7) at visit 1 but decreased to median 2 (IQR: 0–4) at visit 2. In summary, post-COVID persistent cough was similar in overall clinical characteristics to CC. Current cough guideline-based approaches may be effective in most patients with post-COVID cough. Measurement of FeNO levels may also be useful for cough management.
- Files in This Item
-
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/73606)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.